NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+0.68%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$788M
AUM Growth
+$788M
(-4.4%)
Cap. Flow
-$23.9M
Cap. Flow
% of AUM
-3.04%
Top 10 Holdings %
Top 10 Hldgs %
45.27%
Holding
137
New
21
Increased
28
Reduced
38
Closed
17
Top Buys
| 1 |
Assertio
ASRT
|
$12M |
| 2 |
America's Car Mart
CRMT
|
$11.4M |
| 3 |
Zevra Therapeutics
ZVRA
|
$11.1M |
| 4 |
Peloton Interactive
PTON
|
$9.05M |
| 5 |
Neuropace
NPCE
|
$7.74M |
Top Sells
| 1 |
The Bancorp
TBBK
|
$13.2M |
| 2 |
AUTL
Autolus Therapeutics
AUTL
|
$10.2M |
| 3 |
Pathward Financial
CASH
|
$7.8M |
| 4 |
Soleno Therapeutics
SLNO
|
$7.6M |
| 5 |
MediaAlpha
MAX
|
$7.51M |
Sector Composition
| 1 | Healthcare | 53.65% |
| 2 | Consumer Discretionary | 13.83% |
| 3 | Financials | 9.32% |
| 4 | Communication Services | 8.18% |
| 5 | Technology | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPTN
51
DELISTED
OptiNose
OPTN
| $4.07M | 0.35% |
3,307,942
+626,275
| +23% | +$770K |
|
52
IDEAYA Biosciences
IDYA
$2.26B
| $3.94M | 0.34% |
145,860
| – | – |
|
53
Savara
SVRA
$591M
| $3.93M | 0.34% |
+1,039,364
| New | +$3.93M |
|
54
Alta Equipment Group
ALTG
$264M
| $3.89M | 0.33% |
322,632
-100,180
| -24% | -$1.21M |
|
|
AGS
55
DELISTED
PlayAGS
AGS
| $3.88M | 0.33% |
594,574
+42,061
| +8% | +$274K |
|
56
iShares Russell 2000 ETF
IWM
$66.6B
| $3.87M | 0.33% |
21,878
-34,794
| -61% | -$6.15M |
|
57
Evolus
EOLS
$477M
| $3.85M | 0.33% |
+421,220
| New | +$3.85M |
|
58
TELA Bio
TELA
$65.4M
| $3.65M | 0.31% |
456,092
+100,000
| +28% | +$800K |
|
59
Altisource Portfolio Solutions
ASPS
$124M
| $3.61M | 0.31% |
+904,462
| New | +$3.61M |
|
60
Syndax Pharmaceuticals
SNDX
$1.39B
| $3.49M | 0.3% |
240,031
-83,103
| -26% | -$1.21M |
|
|
PNT
61
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $3.48M | 0.3% |
521,191
-51,000
| -9% | -$340K |
|
62
Unicycive Therapeutics
UNCY
$75.8M
| $2.98M | 0.26% |
3,470,541
+2,823,125
| +436% | +$2.43M |
|
63
AYTU BioPharma
AYTU
$21M
| $2.93M | 0.25% |
1,086,812
| – | – |
|
64
Enova International
ENVA
$3B
| $2.71M | 0.23% |
53,250
| – | – |
|
65
Perella Weinberg Partners
PWP
$1.33B
| $2.63M | 0.22% |
258,273
| – | – |
|
66
B. Riley Financial
RILY
$164M
| $2.56M | 0.22% |
62,520
| – | – |
|
67
NN Inc
NNBR
$123M
| $2.52M | 0.22% |
1,353,143
+827,137
| +157% | +$1.54M |
|
68
Tarsus Pharmaceuticals
TARS
$2.44B
| $2.41M | 0.21% |
+135,500
| New | +$2.41M |
|
69
Cidara Therapeutics
CDTX
$1.61B
| $2.39M | 0.2% |
2,538,406
-1,423,492
| -36% | -$1.34M |
|
70
Elutia
ELUT
$84.4M
| $2.36M | 0.2% |
+1,650,000
| New | +$2.36M |
|
71
Cartesian Therapeutics
RNAC
$267M
| $2.33M | 0.2% |
2,200,000
+1,200,000
| +120% | +$1.27M |
|
72
Fossil Group
FOSL
$175M
| $2.03M | 0.17% |
985,215
+65,035
| +7% | +$134K |
|
|
IMTXW
73
DELISTED
Immatics N.V. Warrants
IMTXW
| $1.98M | 0.17% |
558,977
-427,124
| -43% | -$1.51M |
|
74
Strata Skin Sciences
SSKN
$7.84M
| $1.94M | 0.17% |
3,264,945
-1,128,740
| -26% | -$672K |
|
|
75
MediaAlpha
MAX
$613M
| $1.94M | 0.17% |
234,372
-908,613
| -79% | -$7.51M |
|